China, Nov. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Phase 2b, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to evaluate the efficacy and safety of duvakitug in adult participants with moderate to severe hidradenitis suppurativa'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136756

Registration Time: 2026/11/15

Type: Interventional study

Primary Sponsor: West China Hospital of Sichuan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=350934

Published by HT Digital Content Services with permission from Health Daily Digest....